iTeos Therapeutics (ITOS) Stock Chart & Stock Price History $10.17 +0.01 (+0.10%) As of 07/3/2025 03:11 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock iTeos Therapeutics Stock Price Performance The iTeos Therapeutics (ITOS) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 31.19%, with a year-to-date return of 32.42%. In the past month, the stock has decreased 0.29%, reflecting recent market activity. As of the latest close, iTeos Therapeutics traded at $10.17 with a market cap of $389.21 million and volume of 386,108 shares. Receive ITOS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for iTeos Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+2.21%1 Month Performance-0.29%3 Month Performance+88.68%Year-To-Date Performance+32.42%1 Year Performance-31.19% ITOS Stock Chart for Friday, July, 4, 2025 ITOS Chart by TradingView iTeos Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/03/2025$10.16$10.17+0.10%$10.21$10.09386,108 shs$389.21 million07/02/2025$10.00$10.16+1.60%$10.19$9.98668,393 shs$388.82 million07/01/2025$9.97$10.00+0.30%$10.03$9.95838,201 shs$382.74 million06/30/2025$9.95$9.97+0.20%$10.03$9.95717,444 shs$381.55 million06/27/2025$10.02$9.95-0.70%$10.05$9.931.32 million shs$380.79 million06/26/2025$10.04$10.02-0.20%$10.10$9.961.03 million shs$383.47 million06/25/2025$10.09$10.04-0.50%$10.17$10.021.22 million shs$384.23 million06/24/2025$10.11$10.09-0.20%$10.20$10.06740,101 shs$386.14 million06/23/2025$9.96$10.11+1.51%$10.14$9.93939,806 shs$386.95 million06/20/2025$10.00$9.96-0.40%$10.07$9.91992,118 shs$381.17 million Get the Latest News and Ratings for ITOS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for iTeos Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 06/19/2025$10.00$10.00$10.12$9.99650,936 shs$382.70 million06/18/2025$10.02$10.00-0.20%$10.12$9.99650,936 shs$382.74 million06/17/2025$10.10$10.02-0.79%$10.21$10.02776,571 shs$383.51 million06/16/2025$10.17$10.10-0.69%$10.20$10.05883,965 shs$386.57 million06/13/2025$9.98$10.17+1.90%$10.19$9.961.11 million shs$389.25 million06/12/2025$10.00$9.98-0.20%$10.12$9.93668,533 shs$381.98 million06/11/2025$10.03$10.00-0.30%$10.06$9.951.46 million shs$382.74 million06/10/2025$10.04$10.03-0.10%$10.07$9.98539,953 shs$383.89 million06/09/2025$10.17$10.04-1.28%$10.17$9.981.10 million shs$384.27 million06/06/2025$10.18$10.17-0.10%$10.31$10.141.06 million shs$389.25 million06/05/2025$10.20$10.18-0.20%$10.22$10.081.10 million shs$389.63 million06/04/2025$10.10$10.20+0.99%$10.23$10.00691,769 shs$390.40 million06/03/2025$10.01$10.10+0.90%$10.28$9.951.05 million shs$386.57 million Related Companies EWTX Stock Chart SDGR Stock Chart BHVN Stock Chart ETNB Stock Chart ANIP Stock Chart JANX Stock Chart EVO Stock Chart MESO Stock Chart VERA Stock Chart OCUL Stock Chart Receive ITOS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for iTeos Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ITOS) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iTeos Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share iTeos Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ITOS Stock Alerts